vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Fabrinet (FN). Click either name above to swap in a different company.

Fabrinet is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.1× Everus Construction Group, Inc.). Fabrinet runs the higher net margin — 9.9% vs 5.5%, a 4.5% gap on every dollar of revenue. On growth, Fabrinet posted the faster year-over-year revenue change (35.9% vs 33.2%). Everus Construction Group, Inc. produced more free cash flow last quarter ($23.5M vs $-5.3M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 24.4%).

Below is a list of companies having stocks that are included in the S&P MidCap 400 stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies. Although called the S&P 400, the index sometimes contains more than 400 stocks when it includes two or more share classes of stock from one of its component companies.

ECG vs FN — Head-to-Head

Bigger by revenue
FN
FN
1.1× larger
FN
$1.1B
$1.0B
ECG
Growing faster (revenue YoY)
FN
FN
+2.7% gap
FN
35.9%
33.2%
ECG
Higher net margin
FN
FN
4.5% more per $
FN
9.9%
5.5%
ECG
More free cash flow
ECG
ECG
$28.8M more FCF
ECG
$23.5M
$-5.3M
FN
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
24.4%
FN

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ECG
ECG
FN
FN
Revenue
$1.0B
$1.1B
Net Profit
$55.3M
$112.6M
Gross Margin
11.6%
12.2%
Operating Margin
6.8%
10.1%
Net Margin
5.5%
9.9%
Revenue YoY
33.2%
35.9%
Net Profit YoY
60.4%
30.0%
EPS (diluted)
$1.09
$3.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
FN
FN
Q4 25
$1.0B
$1.1B
Q3 25
$986.8M
$978.1M
Q2 25
$921.5M
$909.7M
Q1 25
$826.6M
$871.8M
Q4 24
$759.6M
$833.6M
Q3 24
$761.0M
$804.2M
Q2 24
$703.4M
$753.3M
Q1 24
$625.7M
$731.5M
Net Profit
ECG
ECG
FN
FN
Q4 25
$55.3M
$112.6M
Q3 25
$57.0M
$95.9M
Q2 25
$52.8M
$87.2M
Q1 25
$36.7M
$81.3M
Q4 24
$34.5M
$86.6M
Q3 24
$41.8M
$77.4M
Q2 24
$39.0M
$81.1M
Q1 24
$28.2M
$80.9M
Gross Margin
ECG
ECG
FN
FN
Q4 25
11.6%
12.2%
Q3 25
12.6%
11.9%
Q2 25
13.0%
12.2%
Q1 25
11.2%
11.7%
Q4 24
11.4%
12.1%
Q3 24
11.8%
12.3%
Q2 24
12.6%
12.3%
Q1 24
11.9%
12.4%
Operating Margin
ECG
ECG
FN
FN
Q4 25
6.8%
10.1%
Q3 25
7.3%
9.6%
Q2 25
7.9%
9.8%
Q1 25
6.2%
9.0%
Q4 24
6.1%
9.5%
Q3 24
7.1%
9.6%
Q2 24
7.3%
9.7%
Q1 24
6.2%
9.7%
Net Margin
ECG
ECG
FN
FN
Q4 25
5.5%
9.9%
Q3 25
5.8%
9.8%
Q2 25
5.7%
9.6%
Q1 25
4.4%
9.3%
Q4 24
4.5%
10.4%
Q3 24
5.5%
9.6%
Q2 24
5.5%
10.8%
Q1 24
4.5%
11.1%
EPS (diluted)
ECG
ECG
FN
FN
Q4 25
$1.09
$3.11
Q3 25
$1.11
$2.66
Q2 25
$1.03
$2.41
Q1 25
$0.72
$2.25
Q4 24
$0.68
$2.38
Q3 24
$0.82
$2.13
Q2 24
$0.76
$2.22
Q1 24
$0.55
$2.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
FN
FN
Cash + ST InvestmentsLiquidity on hand
$960.8M
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$629.8M
$2.2B
Total Assets
$1.7B
$3.3B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
FN
FN
Q4 25
$960.8M
Q3 25
$968.8M
Q2 25
$934.2M
Q1 25
$950.7M
Q4 24
$934.6M
Q3 24
$553.0K
$908.9M
Q2 24
$858.6M
Q1 24
$794.0M
Total Debt
ECG
ECG
FN
FN
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ECG
ECG
FN
FN
Q4 25
$629.8M
$2.2B
Q3 25
$573.0M
$2.1B
Q2 25
$514.4M
$2.0B
Q1 25
$460.2M
$1.9B
Q4 24
$422.6M
$1.8B
Q3 24
$453.3M
$1.8B
Q2 24
$490.0M
$1.7B
Q1 24
$464.3M
$1.7B
Total Assets
ECG
ECG
FN
FN
Q4 25
$1.7B
$3.3B
Q3 25
$1.6B
$3.0B
Q2 25
$1.5B
$2.8B
Q1 25
$1.4B
$2.6B
Q4 24
$1.3B
$2.5B
Q3 24
$1.3B
$2.4B
Q2 24
$2.3B
Q1 24
$2.2B
Debt / Equity
ECG
ECG
FN
FN
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
FN
FN
Operating Cash FlowLast quarter
$48.2M
$46.3M
Free Cash FlowOCF − Capex
$23.5M
$-5.3M
FCF MarginFCF / Revenue
2.3%
-0.5%
Capex IntensityCapex / Revenue
2.4%
4.6%
Cash ConversionOCF / Net Profit
0.87×
0.41×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$102.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
FN
FN
Q4 25
$48.2M
$46.3M
Q3 25
$76.2M
$102.6M
Q2 25
$25.3M
$55.1M
Q1 25
$7.1M
$74.2M
Q4 24
$115.9M
Q3 24
$78.9M
$83.2M
Q2 24
$83.1M
Q1 24
$21.9M
$100.9M
Free Cash Flow
ECG
ECG
FN
FN
Q4 25
$23.5M
$-5.3M
Q3 25
$65.7M
$57.3M
Q2 25
$12.3M
$4.7M
Q1 25
$-11.4M
$45.7M
Q4 24
$94.0M
Q3 24
$60.9M
$62.9M
Q2 24
$70.4M
Q1 24
$12.6M
$87.3M
FCF Margin
ECG
ECG
FN
FN
Q4 25
2.3%
-0.5%
Q3 25
6.7%
5.9%
Q2 25
1.3%
0.5%
Q1 25
-1.4%
5.2%
Q4 24
11.3%
Q3 24
8.0%
7.8%
Q2 24
9.3%
Q1 24
2.0%
11.9%
Capex Intensity
ECG
ECG
FN
FN
Q4 25
2.4%
4.6%
Q3 25
1.1%
4.6%
Q2 25
1.4%
5.5%
Q1 25
2.2%
3.3%
Q4 24
2.6%
Q3 24
2.4%
2.5%
Q2 24
1.7%
Q1 24
1.5%
1.9%
Cash Conversion
ECG
ECG
FN
FN
Q4 25
0.87×
0.41×
Q3 25
1.34×
1.07×
Q2 25
0.48×
0.63×
Q1 25
0.19×
0.91×
Q4 24
1.34×
Q3 24
1.89×
1.07×
Q2 24
1.02×
Q1 24
0.77×
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

FN
FN

Optical Communications$832.6M73%
Non Optical Communications$300.3M27%

Related Comparisons